Brain atrophy 15 years after CIS: Baseline and follow-up clinico-radiological correlations

被引:8
作者
Vidal-Jordana, Angela [1 ,2 ]
Sastre-Garriga, Jaume [1 ,2 ]
Pareto, Deborah [3 ,4 ]
Tur, Carmen [1 ,2 ,5 ]
Arrambide, Georgina [1 ,2 ]
Otero-Romero, Susana [1 ,2 ]
Huerga, Elena [3 ,4 ]
Mitjana, Raquel [3 ,4 ]
Auger, Cristina [3 ,4 ]
Tintore, Mar [1 ,2 ]
Rovira, Alex [3 ,4 ]
Montalban, Xavier [1 ,2 ]
机构
[1] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Dept Neurol Neuroimmunol, Edifici Cemcat,P Vall dHebron 119-129, Barcelona 08035, Spain
[2] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Multiple Sclerosis Ctr Catalonia Cemcat, Edifici Cemcat,P Vall dHebron 119-129, Barcelona 08035, Spain
[3] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Dept Radiol, Neuroradiol Sect, Barcelona, Spain
[4] Univ Autonoma Barcelona, Hosp Univ Vall dHebron, Dept Radiol, Magnet Resonance Unit, Barcelona, Spain
[5] UCL Inst Neurol, Queen Sq MS Ctr, Natl Hosp Neurol & Neurosurg, London, England
关键词
Multiple sclerosis; atrophy; grey matter; clinically isolated syndrome; GRAY-MATTER ATROPHY; CLINICALLY ISOLATED SYNDROMES; DEFINITE MULTIPLE-SCLEROSIS; VOLUME CHANGES; DISABILITY PROGRESSION; PREDICT CONVERSION; SEX-DIFFERENCES; GREY; CRITERIA; THERAPY;
D O I
10.1177/1352458517707070
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Brain atrophy in multiple sclerosis (MS) patients is present since the very early stages of the disease and it has been related to long-term disability. Objective: To estimate brain volume (BV) at 15years after a clinically isolated syndrome (CIS) and to evaluate its relationship with disease outcomes. Methods: From a prospective cohort including patients presenting with a CIS, 54 patients with a brain magnetic resonance imaging (MRI) performed 15years after CIS were included. Brain parenchymal fraction (BPF), grey matter fraction (GMF) and white matter fraction (WMF) at 15-year follow-up were obtained. Regression analyses were conducted to predict BV loss and reaching an Expanded Disability Status Scale (EDSS) of 3.0 in that 15-year period. Results: In multivariable analyses, lower values of BPF and WMF were significantly associated with being male, presenting 3-4 Barkhof criteria at baseline, presenting a second relapse, and with a decision to start treatment. In the multivariable logistic regression analysis, only lower GMF was associated with a greater risk of reaching EDSS 3.0 (odds ratio (OR)=0.24, p=0.028). Conclusion: Lower BPF and WMF 15years after CIS are associated with previous markers of inflammatory disease. Lower GMF 15years after a CIS is associated with an increased risk of reaching an EDSS of 3.0.
引用
收藏
页码:721 / 727
页数:7
相关论文
共 30 条
[1]   Regionally Distinct White Matter Lesions Do Not Contribute to Regional Gray Matter Atrophy in Patients with Multiple Sclerosis [J].
Antulov, Ronald ;
Carone, Dominic A. ;
Bruce, Jared ;
Yella, Viritha ;
Dwyer, Michael G. ;
Tjoa, Christopher W. ;
Benedict, Ralph H. B. ;
Zivadinov, Robert .
JOURNAL OF NEUROIMAGING, 2011, 21 (03) :210-218
[2]   Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis [J].
Barkhof, F ;
Filippi, M ;
Miller, DH ;
Scheltens, P ;
Campi, A ;
Polman, CH ;
Comi, G ;
Ader, HJ ;
Losseff, N ;
Valk, J .
BRAIN, 1997, 120 :2059-2069
[3]   The predictive value of gray matter atrophy in clinically isolated syndromes [J].
Calabrese, M. ;
Rinaldi, F. ;
Mattisi, I. ;
Bernardi, V. ;
Favaretto, A. ;
Perini, P. ;
Gallo, P. .
NEUROLOGY, 2011, 77 (03) :257-263
[4]   Grey matter atrophy is associated with disability increase in natalizumab-treated patients [J].
Ciampi, Ethel ;
Pareto, Deborah ;
Sastre-Garriga, Jaume ;
Vidal-Jordana, Angela ;
Tur, Carmen ;
Rio, Jordi ;
Tintore, Mar ;
Auger, Cristina ;
Rovira, Alex ;
Montalban, Xavier .
MULTIPLE SCLEROSIS JOURNAL, 2017, 23 (04) :556-566
[5]   Sex differences in brain aging - A quantitative magnetic resonance imaging study [J].
Coffey, CE ;
Lucke, JF ;
Saxton, JA ;
Ratcliff, G ;
Unitas, LJ ;
Billig, B ;
Bryan, RN .
ARCHIVES OF NEUROLOGY, 1998, 55 (02) :169-179
[6]   Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process [J].
Confavreux, C ;
Vukusic, S ;
Adeleine, P .
BRAIN, 2003, 126 :770-782
[7]   Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes [J].
Dalton, CM ;
Chard, DT ;
Davies, GR ;
Miszkiel, KA ;
Altmann, DR ;
Fernando, K ;
Plant, GT ;
Thompson, AJ ;
Miller, DH .
BRAIN, 2004, 127 :1101-1107
[8]   Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes [J].
De Stefano, N. ;
Giorgio, A. ;
Battaglini, M. ;
Rovaris, M. ;
Sormani, M. P. ;
Barkhof, F. ;
Korteweg, T. ;
Enzinger, C. ;
Fazekas, F. ;
Calabrese, M. ;
Dinacci, D. ;
Tedeschi, G. ;
Gass, A. ;
Montalban, X. ;
Rovira, A. ;
Thompson, A. ;
Comi, G. ;
Miller, D. H. ;
Filippi, M. .
NEUROLOGY, 2010, 74 (23) :1868-1876
[9]   Establishing pathological cut-offs of brain atrophy rates in multiple sclerosis [J].
De Stefano, Nicola ;
Stromillo, Maria Laura ;
Giorgio, Antonio ;
Bartolozzi, Maria Letizia ;
Battaglini, Marco ;
Baldini, Mariella ;
Portaccio, Emilio ;
Amato, Maria Pia ;
Sormani, Maria Pia .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2016, 87 (01) :93-99
[10]   MRI measures of neurodegeneration in multiple sclerosis: implications for disability, disease monitoring, and treatment [J].
Filippi, Massimo .
JOURNAL OF NEUROLOGY, 2015, 262 (01) :1-6